Literature DB >> 15220280

Diabetes is still a risk factor for restenosis after drug-eluting stent in coronary arteries.

André J Scheen, Fabian Warzée.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15220280     DOI： 10.2337/diacare.27.7.1840

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  8 in total

Review 1.  Vascular repair strategies in type 2 diabetes: novel insights.

Authors:  Kira Kuschnerus; Ulf Landmesser; Nicolle Kränkel
Journal:  Cardiovasc Diagn Ther       Date:  2015-10

Review 2.  Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.

Authors:  C Stettler; S Allemann; M Egger; S Windecker; B Meier; P Diem
Journal:  Heart       Date:  2005-10-26       Impact factor: 5.994

3.  Long-term type 1 diabetes enhances in-stent restenosis after aortic stenting in diabetes-prone BB rats.

Authors:  Geanina Onuta; Hendrik C Groenewegen; Flip A Klatter; Mark Walther Boer; Maaike Goris; Harry van Goor; Anton J M Roks; Jan Rozing; Bart J G L de Smet; Jan-Luuk Hillebrands
Journal:  J Biomed Biotechnol       Date:  2011-02-09

4.  Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury.

Authors:  Yuichi Terawaki; Takashi Nomiyama; Takako Kawanami; Yuriko Hamaguchi; Hiroyuki Takahashi; Tomoko Tanaka; Kunitaka Murase; Ryoko Nagaishi; Makito Tanabe; Toshihiko Yanase
Journal:  Cardiovasc Diabetol       Date:  2014-11-19       Impact factor: 9.951

Review 5.  Diabetes and restenosis.

Authors:  Scott Wilson; Pasquale Mone; Urna Kansakar; Stanislovas S Jankauskas; Kwame Donkor; Ayobami Adebayo; Fahimeh Varzideh; Michael Eacobacci; Jessica Gambardella; Angela Lombardi; Gaetano Santulli
Journal:  Cardiovasc Diabetol       Date:  2022-02-14       Impact factor: 9.951

6.  Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.

Authors:  Sripal Bangalore; Sunil Kumar; Mario Fusaro; Nicholas Amoroso; Ajay J Kirtane; Robert A Byrne; David O Williams; James Slater; Donald E Cutlip; Frederick Feit
Journal:  BMJ       Date:  2012-08-10

7.  Oxidative stress-induced cellular senescence desensitizes cell growth and migration of vascular smooth muscle cells through down-regulation of platelet-derived growth factor receptor-beta.

Authors:  Chun-Hsu Pan; Chang-Jui Chen; Chun-Ming Shih; Ming-Fu Wang; Jie-Yu Wang; Chieh-Hsi Wu
Journal:  Aging (Albany NY)       Date:  2019-10-03       Impact factor: 5.682

8.  Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression.

Authors:  Toru Shigeoka; Takashi Nomiyama; Takako Kawanami; Yuriko Hamaguchi; Tsuyoshi Horikawa; Tomoko Tanaka; Shinichiro Irie; Ryoko Motonaga; Nobuya Hamanoue; Makito Tanabe; Kazuki Nabeshima; Masatoshi Tanaka; Toshihiko Yanase; Daiji Kawanami
Journal:  J Diabetes Investig       Date:  2020-04-09       Impact factor: 4.232
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.